Boston Scientific to Acquire Nalu Medical - Gilde Healthcare

Menu
Menu
Home

Boston Scientific to Acquire Nalu Medical

Geoff Pardo

General Partner Healthtech
Venture&Growth
Vereinigte Staaten

Karthik Bolisetty

Investment Manager Healthtech
Venture&Growth
Vereinigte Staaten
17. Oktober 2025
Utrecht (the Netherlands) & Boston, MA (United States)

We are pleased to announce the strategic exit of our portfolio company Nalu Medical. Boston Scientific, a global leader in medical technology, has agreed to acquire Gilde Healthcare portfolio company Nalu Medical at a $600m valuation.

Nalu Medical markets a miniaturized implantable neurostimulation device to treat patients with chronic neuropathic pain.
Boston Scientific expects to complete the transaction in the first half of 2026, subject to customary closing conditions.

Gilde Healthcare co led the $104m financing round in 2022 and Geoff Pardo serves on the Board of Directors.

Press Release

Mehr neuigkeiten

Gilde Gilde Healthcare Portfolio company SpliceBio Initiates Dose-Expansion Portion of Phase 1/2 ASTRA Clinical Trial for SB-007 for Stargardt Disease

First dose-expansion patient successfully received SB-007  SB-007 addresses the root cause of Stargardt disease with the potential to treat patients across all ABCA4 mutations  SB-007 granted FDA Fast Track designation, following previously received Orphan Drug...
9. Januar 2026

Gilde Healthcare erwirbt einen Mehrheitsanteil an Physio CKI, einer physiotherapeutischen Praxisgruppe, von Kapital 1852

Der Private Equity Fonds von Gilde Healthcare gibt den Erwerb der Mehrheitsanteile an Physio CKI von Kapital 1852 bekannt. Physio CKI ist eine wachstumsstarke Gruppe von Physiotherapiepraxen mit Hauptsitz in Köln. Gründer und Geschäftsführer Chaled...
22. Dezember 2025

Okami Medical Announces $45 Million Financing and New CEO Appointment to Drive Next Phase of Growth

Okami Medical, a medical technology company pioneering novel vascular embolization solutions, today announced the successful close of an oversubscribed $45M financing led by new investor Gilde Healthcare with participation from existing investors including Vensana Capital and...
20. November 2025